Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.53 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | MMP2 | P08253 | 2/20 | 0.49 |
| ▸ | MMP9 | P14780 | 2/20 | 0.49 |
| ▸ | MMP12 | P39900 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | CASP3 | P42574 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.48 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.48 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.47 |
| ▸ | MMP1 | P03956 | 1/20 | 0.47 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2167257 | 0.94 | POLB (0.50) | TDP1KMT2ASLC6A2SLC6A3POLB | |
| SCHEMBL4014439 | 0.88 | KMT2A (0.48) | TDP1KMT2ASLC6A2SLC6A3POLB | |
| SCHEMBL28413301 | 0.88 | KMT2A (0.53) | TDP1KMT2ASLC6A2SLC6A3POLB | |
| SCHEMBL11181967 | 0.80 | CASP3 (0.58) | TDP1KMT2APOLBLMNAMMP2 | |
| SCHEMBL5918034 | 0.79 | RXFP1 (0.61) | KMT2APOLBLMNAALDH1A1TSHR | |
| SCHEMBL2421709 | 0.79 | KMT2A (0.42) | KMT2APOLBL3MBTL1TSHRRAB9A | |
| SCHEMBL24844709 | 0.78 | MMP12 (0.51) | TDP1KMT2AMMP2MMP9MMP12 | |
| SCHEMBL11411711 | 0.77 | RAB9A (0.41) | KMT2AALDH1A1L3MBTL1TSHRRAB9A | |
| SCHEMBL28415823 | 0.77 | NPC1 (0.42) | KMT2ASLC6A2SLC6A3POLBLMNA | |
| SCHEMBL11836426 | 0.76 | KMT2A (0.47) | TDP1KMT2AALDH1A1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107148453-B | Photocurable composition | 思美定株式会社 | 2021-08-17 | — | — | CN | disclosed |
| CN-108431157-B | Bonding method using photocurable adhesive | 思美定株式会社 | 2021-02-05 | — | — | CN | disclosed |
| US-10844251-B2 | Pressure-sensitive adhesive | CEMEDINE CO., LTD. (JP) | 2020-11-24 | — | — | US | disclosed |
| CN-105392845-B | Photocurable composition | 思美定株式会社 | 2020-10-20 | — | — | CN | disclosed |
| CN-107532061-B | Pressure-sensitive adhesive | 思美定株式会社 | 2020-03-03 | — | — | CN | disclosed |
| EP-3081612-B1 | PHOTOCURABLE COMPOSITION HAVING ADHESIVE PROPERTIES | CEMEDINE CO LTD (JP) | 2018-11-14 | — | — | EP | disclosed |
| US-20180298239-A1 | PRESSURE-SENSITIVE ADHESIVE | CEMEDINE CO., LTD. (JP) | 2018-10-18 | — | — | US | disclosed |
| US-10029989-B2 | Imidazole derivatives | HOFFMANN-LA ROCHE INC. (US) | 2018-07-24 | — | — | US | disclosed |
| US-20180118692-A1 | IMIDAZOLE DERIVATIVES | HOFFMANN-LA ROCHE INC. (US) | 2018-05-03 | — | — | US | disclosed |
| EP-3287501-A1 | PRESSURE-SENSITIVE ADHESIVE | Cemedine Co., Ltd. (JP) | 2018-02-28 | — | — | EP | disclosed |
| WO-1995017403-A1 | GUANINE SYNTHONS FOR PEPTIDE NUCLEIC ACID SYNTHESIS AND METHOD FOR PRODUCTION | PERSEPTIVE BIOSYSTEMS, INC. (US) | 1995-06-29 | — | — | WO | disclosed |
| EP-0633935-A1 | STABILITY-ENHANCED VARIANTS OF PARATHYROID HORMONE | Allelix Biopharmaceuticals Inc. (CA) | 1995-01-18 | — | — | EP | disclosed |
| EP-0048614-B1 | 1-N-ACYLATED AND 1-N-ALKYLATED DERIVATIVES OF 4-0-SUBSTITUTED -2-DEOXYSTREPTAMINE AMINOGLYCOSIDES | ELI LILLY AND COMPANY (US) | 1985-03-20 | — | — | EP | disclosed |
| EP-0048613-B1 | 4-0-SUBSTITUTED -2-DEOXYSTREPTAMINE AMINOGLYCOSIDE DERIVATIVES, THEIR PREPARATION AND FORMULATIONS CONTAINING THEM | ELI LILLY AND COMPANY (US) | 1985-01-23 | — | — | EP | disclosed |
| US-4468513-A | 2'-N-Acylated and 2'-N-alkylated derivatives of 4-O-substituted-2-deoxystreptamine aminoglycosides | ELI LILLY AND COMPANY (US) | 1984-08-28 | — | — | US | disclosed |
| US-4468512-A | 1-N-Acylated and 1-N-alkylated derivatives of 4-O-substituted-2-deoxystreptamine aminoglycosides | ELI LILLY AND COMPANY (US) | 1984-08-28 | — | — | US | disclosed |
| US-4424344-A | 2-N-Acylated and 2-N-alkylated derivatives of 4-O-substituted-2-deoxystreptamine aminoglycosides and process | ELI LILLY AND COMPANY (US) | 1984-01-03 | — | — | US | disclosed |
| US-4424345-A | 1-N-Acylated and 1-N-alkylated derivatives of 4-O-substituted-2-deoxystreptamine aminoglycosides and process | ELI LILLY AND COMPANY (US) | 1984-01-03 | — | — | US | disclosed |
| EP-0048613-A1 | 4-0-Substituted -2-deoxystreptamine aminoglycoside derivatives, their preparation and formulations containing them | ELI LILLY AND COMPANY (US) | 1982-03-31 | — | — | EP | disclosed |
| EP-0048614-A1 | 1-N-acylated and 1-N-alkylated derivatives of 4-0-substituted -2-deoxystreptamine aminoglycosides | ELI LILLY AND COMPANY (US) | 1982-03-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180118692-A1 | IMIDAZOLE DERIVATIVES | DRD3, GABRR3, DRD4 | TDP1 2555/4885KMT2A 2209/4885SLC6A2 906/4885 |
| US-10029989-B2 | Imidazole derivatives | DRD3, GABRR3, DRD4 | TDP1 2555/4885KMT2A 2209/4885SLC6A2 906/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.